vs
Side-by-side financial comparison of KENNAMETAL INC (KMT) and Bio-Techne (TECH). Click either name above to swap in a different company.
KENNAMETAL INC is the larger business by last-quarter revenue ($529.5M vs $295.9M, roughly 1.8× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs 6.4%, a 6.4% gap on every dollar of revenue. On growth, KENNAMETAL INC posted the faster year-over-year revenue change (9.8% vs -6.4%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs 1.3%).
Kennametal, Inc. is a manufacturer of high-performance cutting tools and engineered components used in the aerospace, defense, transportation and oil and gas drilling industries. Its customer base is global.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
KMT vs TECH — Head-to-Head
Income Statement — Q2 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $529.5M | $295.9M |
| Net Profit | $33.9M | $38.0M |
| Gross Margin | 32.8% | 64.6% |
| Operating Margin | 9.9% | 18.4% |
| Net Margin | 6.4% | 12.8% |
| Revenue YoY | 9.8% | -6.4% |
| Net Profit YoY | 89.0% | 68.3% |
| EPS (diluted) | $0.44 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $529.5M | $295.9M | ||
| Q3 25 | $498.0M | — | ||
| Q2 25 | $516.4M | $317.0M | ||
| Q1 25 | $486.4M | $316.2M | ||
| Q4 24 | $482.1M | $297.0M | ||
| Q3 24 | $481.9M | $289.5M | ||
| Q2 24 | $543.3M | $306.1M | ||
| Q1 24 | $515.8M | $303.4M |
| Q4 25 | $33.9M | $38.0M | ||
| Q3 25 | $23.3M | — | ||
| Q2 25 | $21.6M | $-17.7M | ||
| Q1 25 | $31.5M | $22.6M | ||
| Q4 24 | $17.9M | $34.9M | ||
| Q3 24 | $22.1M | $33.6M | ||
| Q2 24 | $37.2M | $40.6M | ||
| Q1 24 | $19.0M | $49.1M |
| Q4 25 | 32.8% | 64.6% | ||
| Q3 25 | 31.0% | — | ||
| Q2 25 | 28.2% | 62.7% | ||
| Q1 25 | 32.1% | 67.9% | ||
| Q4 24 | 30.1% | 65.3% | ||
| Q3 24 | 31.3% | 63.2% | ||
| Q2 24 | 31.5% | 66.4% | ||
| Q1 24 | 29.7% | 67.4% |
| Q4 25 | 9.9% | 18.4% | ||
| Q3 25 | 7.5% | — | ||
| Q2 25 | 6.1% | -7.5% | ||
| Q1 25 | 9.1% | 12.2% | ||
| Q4 24 | 6.6% | 16.0% | ||
| Q3 24 | 7.5% | 13.8% | ||
| Q2 24 | 11.3% | 15.0% | ||
| Q1 24 | 6.8% | 22.1% |
| Q4 25 | 6.4% | 12.8% | ||
| Q3 25 | 4.7% | — | ||
| Q2 25 | 4.2% | -5.6% | ||
| Q1 25 | 6.5% | 7.1% | ||
| Q4 24 | 3.7% | 11.7% | ||
| Q3 24 | 4.6% | 11.6% | ||
| Q2 24 | 6.8% | 13.3% | ||
| Q1 24 | 3.7% | 16.2% |
| Q4 25 | $0.44 | $0.24 | ||
| Q3 25 | $0.30 | — | ||
| Q2 25 | $0.28 | $-0.11 | ||
| Q1 25 | $0.41 | $0.14 | ||
| Q4 24 | $0.23 | $0.22 | ||
| Q3 24 | $0.28 | $0.21 | ||
| Q2 24 | $0.47 | $0.26 | ||
| Q1 24 | $0.24 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $129.3M | $172.9M |
| Total DebtLower is stronger | $597.2M | $260.0M |
| Stockholders' EquityBook value | $1.3B | $2.0B |
| Total Assets | $2.6B | $2.5B |
| Debt / EquityLower = less leverage | 0.45× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $129.3M | $172.9M | ||
| Q3 25 | $103.5M | — | ||
| Q2 25 | $140.5M | $162.2M | ||
| Q1 25 | $97.5M | $140.7M | ||
| Q4 24 | $121.2M | $177.5M | ||
| Q3 24 | $119.6M | $187.5M | ||
| Q2 24 | $128.0M | $152.9M | ||
| Q1 24 | $92.1M | $145.3M |
| Q4 25 | $597.2M | $260.0M | ||
| Q3 25 | $597.0M | — | ||
| Q2 25 | $596.8M | $346.0M | ||
| Q1 25 | $596.6M | $330.0M | ||
| Q4 24 | $596.4M | $300.0M | ||
| Q3 24 | $596.2M | $300.0M | ||
| Q2 24 | $596.0M | $319.0M | ||
| Q1 24 | $595.8M | $389.0M |
| Q4 25 | $1.3B | $2.0B | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.3B | $1.9B | ||
| Q1 25 | $1.2B | $2.0B | ||
| Q4 24 | $1.2B | $2.1B | ||
| Q3 24 | $1.3B | $2.1B | ||
| Q2 24 | $1.2B | $2.1B | ||
| Q1 24 | $1.3B | $2.0B |
| Q4 25 | $2.6B | $2.5B | ||
| Q3 25 | $2.5B | — | ||
| Q2 25 | $2.5B | $2.6B | ||
| Q1 25 | $2.5B | $2.6B | ||
| Q4 24 | $2.4B | $2.7B | ||
| Q3 24 | $2.5B | $2.7B | ||
| Q2 24 | $2.5B | $2.7B | ||
| Q1 24 | $2.5B | $2.7B |
| Q4 25 | 0.45× | 0.13× | ||
| Q3 25 | 0.46× | — | ||
| Q2 25 | 0.46× | 0.18× | ||
| Q1 25 | 0.48× | 0.16× | ||
| Q4 24 | 0.49× | 0.14× | ||
| Q3 24 | 0.47× | 0.14× | ||
| Q2 24 | 0.48× | 0.15× | ||
| Q1 24 | 0.47× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $55.1M | — |
| Free Cash FlowOCF − Capex | $42.4M | — |
| FCF MarginFCF / Revenue | 8.0% | — |
| Capex IntensityCapex / Revenue | 2.4% | — |
| Cash ConversionOCF / Net Profit | 1.63× | — |
| TTM Free Cash FlowTrailing 4 quarters | $99.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $55.1M | — | ||
| Q3 25 | $17.5M | — | ||
| Q2 25 | $78.6M | $98.2M | ||
| Q1 25 | $28.8M | $41.1M | ||
| Q4 24 | $55.2M | $84.3M | ||
| Q3 24 | $45.7M | $63.9M | ||
| Q2 24 | $113.6M | $75.5M | ||
| Q1 24 | $75.2M | $81.0M |
| Q4 25 | $42.4M | — | ||
| Q3 25 | $-5.5M | — | ||
| Q2 25 | $57.1M | $93.3M | ||
| Q1 25 | $5.3M | $31.0M | ||
| Q4 24 | $35.9M | $77.5M | ||
| Q3 24 | $21.0M | $54.7M | ||
| Q2 24 | $90.3M | $57.5M | ||
| Q1 24 | $48.4M | $64.5M |
| Q4 25 | 8.0% | — | ||
| Q3 25 | -1.1% | — | ||
| Q2 25 | 11.1% | 29.4% | ||
| Q1 25 | 1.1% | 9.8% | ||
| Q4 24 | 7.5% | 26.1% | ||
| Q3 24 | 4.4% | 18.9% | ||
| Q2 24 | 16.6% | 18.8% | ||
| Q1 24 | 9.4% | 21.3% |
| Q4 25 | 2.4% | — | ||
| Q3 25 | 4.6% | — | ||
| Q2 25 | 4.2% | 1.5% | ||
| Q1 25 | 4.8% | 3.2% | ||
| Q4 24 | 4.0% | 2.3% | ||
| Q3 24 | 5.1% | 3.2% | ||
| Q2 24 | 4.3% | 5.9% | ||
| Q1 24 | 5.2% | 5.4% |
| Q4 25 | 1.63× | — | ||
| Q3 25 | 0.75× | — | ||
| Q2 25 | 3.64× | — | ||
| Q1 25 | 0.92× | 1.82× | ||
| Q4 24 | 3.08× | 2.42× | ||
| Q3 24 | 2.07× | 1.90× | ||
| Q2 24 | 3.06× | 1.86× | ||
| Q1 24 | 3.96× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KMT
| Metal Cutting | $331.1M | 63% |
| Infrastructure | $198.5M | 37% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
